Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Page

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Annals of the American Thoracic Society|September 7, 2021
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome: A Randomized Pilot Clinical TrialDavid B Page, Kadambari Vijaykumar, Derek W Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New TherapiesBernard A Fox, Walter J Urba, Shawn M Jensen, et al.
Journal of Bone Oncology|June 20, 2017
Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone scoreVeronica Mariotti, David B Page, Oksana Davydov, et al.
Breast Cancer Research and Treatment|October 8, 2017
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impactDavid B Page, Hannah Wen, Edi Brogi, et al.
Frontiers in Oncology|June 25, 2021
A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 TherapyIsaac Kim, Venkatesh Rajamanickam, Brady Bernard, et al.
Cancer Immunology Research|April 30, 2014
Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumabJianda Yuan, Jun Zhou, Zhiwan Dong, et al.
Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.
Leukemia & Lymphoma|May 31, 2017
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myelomaMatthew J Pianko, Samuel A Funt, David B Page, et al.
Breast Cancer Research : BCR|January 8, 2021
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancerKatherine Sanchez, Isaac Kim, Brie Chun, et al.
Brain Injury|January 18, 2021
Factors Increasing Risk of Suicide after Traumatic Brain Injury: A State-of-the-Science Review of Military and Civilian StudiesKayla L McIntire, Kelly M Crawford, Paul B Perrin, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Annals of the American Thoracic Society|September 7, 2021
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome: A Randomized Pilot Clinical TrialDavid B Page, Kadambari Vijaykumar, Derek W Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New TherapiesBernard A Fox, Walter J Urba, Shawn M Jensen, et al.
Journal of Bone Oncology|June 20, 2017
Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone scoreVeronica Mariotti, David B Page, Oksana Davydov, et al.
Breast Cancer Research and Treatment|October 8, 2017
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impactDavid B Page, Hannah Wen, Edi Brogi, et al.
Frontiers in Oncology|June 25, 2021
A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 TherapyIsaac Kim, Venkatesh Rajamanickam, Brady Bernard, et al.
Cancer Immunology Research|April 30, 2014
Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumabJianda Yuan, Jun Zhou, Zhiwan Dong, et al.
Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.
Leukemia & Lymphoma|May 31, 2017
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myelomaMatthew J Pianko, Samuel A Funt, David B Page, et al.
Breast Cancer Research : BCR|January 8, 2021
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancerKatherine Sanchez, Isaac Kim, Brie Chun, et al.
Brain Injury|January 18, 2021
Factors Increasing Risk of Suicide after Traumatic Brain Injury: A State-of-the-Science Review of Military and Civilian StudiesKayla L McIntire, Kelly M Crawford, Paul B Perrin, et al.
Pageof 7